Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaana Oikkonen

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Cancer Research|November 12, 2025
Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian CancerBarun Pradhan, Jaana Oikkonen, Kaiyang Zhang, et al.
Cell Reports. Medicine|August 30, 2025
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancerDaria Afenteva, Rong Yu, Anna Rajavuori, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancerInga-Maria Launonen, Erdogan Pekcan Erkan, Iga Niemiec, et al.
Cancer Cell|December 10, 2024
Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancerInga-Maria Launonen, Iga Niemiec, María Hincapié-Otero, et al.
Genome Medicine|July 4, 2026
Multi-modal data integration reveals functionally credible predictive biomarkers in ovarian cancerTaru A Muranen, Andreas Hainari, Daria Afenteva, et al.
Developmental Cell|May 6, 2023
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoidsWojciech Senkowski, Laura Gall-Mas, Matías Marín Falco, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cancer Research|November 12, 2025
Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian CancerBarun Pradhan, Jaana Oikkonen, Kaiyang Zhang, et al.
Cell Reports. Medicine|August 30, 2025
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancerDaria Afenteva, Rong Yu, Anna Rajavuori, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancerInga-Maria Launonen, Erdogan Pekcan Erkan, Iga Niemiec, et al.
Cancer Cell|December 10, 2024
Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancerInga-Maria Launonen, Iga Niemiec, María Hincapié-Otero, et al.
Genome Medicine|July 4, 2026
Multi-modal data integration reveals functionally credible predictive biomarkers in ovarian cancerTaru A Muranen, Andreas Hainari, Daria Afenteva, et al.
Developmental Cell|May 6, 2023
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoidsWojciech Senkowski, Laura Gall-Mas, Matías Marín Falco, et al.
Pageof 4